Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127009241 | 12700924 | 1 | I | 20160825 | 20160830 | 20160830 | PER | US-CELGENEUS-USA-2016086925 | CELGENE | 0.00 | F | Y | 0.00000 | 20160830 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127009241 | 12700924 | 1 | PS | OTEZLA | APREMILAST | 1 | Oral | 60 MILLIGRAM | U | 205437 | 30 | MG | TABLETS | BID | |||||
| 127009241 | 12700924 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | Y | U | 0 | UNKNOWN | ||||||||
| 127009241 | 12700924 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | Y | U | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127009241 | 12700924 | 1 | Psoriatic arthropathy |
| 127009241 | 12700924 | 2 | Product used for unknown indication |
| 127009241 | 12700924 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127009241 | 12700924 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127009241 | 12700924 | 1 | 20141229 | 0 |